X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2024-04-11 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $25.04 | -30,000 | 1,117,035 | -3% | -$751,332 | |||||
D | 2024-04-01 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $18.60 | -12,000 | 1,117,035 | -1% | -$223,146 | |||||
D | 2024-02-29 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $16.42 | -12,000 | 1,117,035 | -1% | -$197,006 | |||||
D | 2024-01-29 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $15.85 | -12,000 | 1,117,035 | -1% | -$190,256 | |||||
D | 2023-12-29 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $14.28 | -12,000 | 1,117,035 | -1% | -$171,381 | |||||
DM | 2023-12-21 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $13.07 | -6,566 | 1,117,035 | -1% | -$85,790 | |||||
DM | 2023-12-19 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $13.01 | -8,888 | 1,117,035 | -1% | -$115,646 | |||||
D | 2023-11-03 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $13.08 | -8,546 | 1,117,035 | -1% | -$111,751 | |||||
D | 2023-09-29 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $13.62 | -12,000 | 1,117,035 | -1% | -$163,498 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |